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Background: Opioids have been used for the management of pain and coadministration of two opioids may
induce synergism. In a model of tonic pain, the acetic acid writhing test and in a phasic model, the hot plate, the
antinociceptive interaction between fentanyl, methadone, morphine, and tramadol was evaluated.
Results: The potency of opioids in the writhing test compared to the hot plate assay was from 2.5 (fentanyl) to
15.5 (morphine) times, respectively. The ED50 was used in a fixed ratio for each of the six pairs of opioid
combinations, which, resulted in a synergistic antinociception except for methadone/tramadol and fentanyl/
tramadol which were additive, in the hot plate. The opioid antagonists naltrexone, naltrindole and nor-binaltorphimine,
suggests that the synergism of morphine combinations are due to the activation of MOR subtypes with partially
contribution of DOR and KOR, however fentanyl and methadone combinations are partially due to the activation of
MOR and DOR subtypes and KOR lack of participation. The antinociceptive effects of tramadol combinations, are
partially due to the activation of MOR, DOR and KOR opioid subtypes.
Conclusion: These results suggets that effectiveness and magnitude of the interactions between opioids are
dependent on pain stimulus intensity.
Keywords: Interaction opioid-opioid, Acetic acid writhing test, Hot plate assay, Isobolographic analysis, SynergismBackground
Opioids have been the main drugs used in the manage-
ment of pain for several decades. However, repeated use
of opioids, such as morphine and heroin, cause analgesic
tolerance, physical dependence, and opioid addiction [1].
Opioid effects are mediated by three major types of opioid
receptors: μ-, δ-, and κ-opioid receptors (MORs, DORs,
and KORs, respectively) [2]. Previous studies have shown
that majority of opioid effects, including analgesia, tole-
rance, and addiction, are primarily mediated by MORs,
however the effects of the other two opioid receptors re-
main elusive [1,2]. Several types of analgesic combinations
are available for the treatment of pain, using drugs which* Correspondence: hmiranda@med.chile.cl
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unless otherwise stated.differ in their mechanisms of action with the aim of
maximize therapeutic efficacy while minimizing side ef-
fects. Also, fixed ratio drug combinations are widely used
[3]. Combinations between different non-steroidal anti-
inflammatory drugs (NSAIDs) and opioids, have been
evaluated either experimentally or clinically [4-8]. How-
ever, combinations of two opioid receptor agonists have
been poorly explored experimentally [9,10]. There is
scarce information about clinical trials performed with
opioid associations in patients affected by pain [11].
From the theoretical point of view, the combination
opioid-opioid could induce an adequate control of pain,
with a reduced doses and less adverse effects.
In this study, a tonic model of induced pain, the writh-
ing test was selected as a model of acute visceral pain,
because it seems to be a model of clinical relevancy in
intestinal pain in humans [12]. The acetic acid is an easy
and fast screening model to access the activity of analgesicl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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acteristic and quantifiable overt pain-like behaviour de-
scribed as a writhing response or abdominal contortion
[13]. A phasic model of induced pain was also utilized, the
hot plate assay [14]. In this assay, the latency to pain reflex
behaviour is measured.
The purpose of this study was to evaluate the inter-
action between all possible combinations of the follow-
ing opioids: morphine, methadone, tramadol and fentanyl,
in both models of pain. The analysis of the interaction was
carried out by isobolographic analysis with the calcula-
tions of the interactions indexes. Besides the role of the
antagonists of different subtypes of opioid receptors in the
interaction was evaluated.
Methods
In all experiments CF-1 male mice, weighing 28–30 g,
housed in a 12-h light–dark cycle at 22 ± 1°C, with free
access to food and water were used. The animals were
acclimatized to the laboratory environment for at least
2 h before use. Experiments were carried out in accord-
ance with the Guide for the Care and Use of Laboratory
Animals issued by the National Institute of Health, and
experimental procedures were approved by the Institu-
tional Animal Care and Use Committee at the Universi-
dad de Chile, Santiago, Chile. Each animal was used only
once, and received only one dose of the drugs tested. All
drugs were freshly prepared by dissolving them in nor-
mal saline, and administered intraperitoneally (i.p.). The
authors performed all observations in a randomized and
blind manner. Control saline animals were run inter-
spersed concurrently with the drug-treated animals (at
least two mice per group), which prevented all the con-
trols being run on a single group of mice at one time
during the course of the research.
Acetic acid writhing test
A modification of the method previously described was
used [15]. To perform the test, mice were injected i.p.
with10 mL/kg of 0.6% acetic acid solution, 30 min after
the i.p. administration of the drugs, a time at which pre-
liminary experiments showed the occurrence of the ma-
ximum effect. A writhe is characterized by a wave of
contractions of the abdominal musculature, followed by
the extension of the hind limbs. The number of writhes
in a 5 min period was counted, starting 5 min after the
administration of acetic acid. Antinociceptive activity
was expressed as the maximum possible effect (% MPE)
of the percent inhibition of the usual number of writhes
observed in control animals ( 20.4 ± 0.36, n = 12). The
dose of the drug that produced 50% of MPE (ED50) was
calculated from the linear regression analysis of the
curve obtained by plotting log dose vs percentage of
MPE.Hot plate test
This thermal antinociceptive test was performed accor-
ding with a modification to the method of Eddy and
Leimbach [16]. A commercial device (Ugo Basile, Italy)
was calibrated at 50 ± 0.2°C and the cut-off time was set
at 30 sec. Each mouse was placed on the heated surface
and the time, in sec, between placement and licking or
shaking the hind paw or jumping was recorded as re-
sponse latency and is a sign of thermal nociception. Each
animal was tested twice before (control latency = 15.50 ±
0.40) and after the drug administration and the antinoci-
ceptive activity and was expressed as the maximum pos-
sible effect (MPE) using the formula:
%MPE ¼ ½ drug latency – control latencyð Þ=
30 sec–control latencyð Þ  100
Protocols
Writhing and hot plate test
Dose–response curves for i.p. administration of the fol-
lowing opioids: morphine, methadone, fentanyl and
tramadol were obtained using eight animals with at least
four doses for each. Linear regression analysis of the log
dose–response curves allowed the calculation of the do-
ses that produced 50% of antinociception (ED50), when
each drug was administered alone. ED50 was used in the
acetic acid writhing test or in the hot plate assay, as the
equieffective dose for isobolographic analysis. Then a si-
milar dose–response curve was also obtained and analysed
after the coadministration of morphine with methadone,
fentanyl and tramadol. Similarly, after the coadministra-
tion of methadone with fentanyl and tramadol, and finally,
coadministration of fentanyl and tramadol. The dose–re-
sponse curve was obtained by the intraperitoneal coad-
ministration of each mixture of opioids in fixed ratio
combinations of fractions of their respective ED50 values:
1/2, 1/4, 1/8, 1/16. In addition, the effect of the pretreat-
ment on the mice with naltrexone (NTX), naltrindole
(NTI) and nor-binaltorphimine (nor-BNI) in the antinoci-
ception induced by the coadministration of opioids was
evaluated.
Isobolographic analysis
Isobolographic analysis was used to characterize drug in-
teractions. The method of isobolographic analysis has
been previously described in detail [5,17]. The isobolo-
grams were constructed by connecting the ED50 of one
opioid plotted on the abscissa with the ED50 of other
opioid plotted on the ordinate, to obtain the additive
line. For each mixture of opioids, the ED50 and its asso-
ciated 95% confidence intervals (CL) were determined
by linear regression analysis of the log dose–response
curve (eight animals at each with at least four doses),
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that was obtained from: ED50 add = ED50 one opioid/
(P1 + R X P2 ) where R is the potency ratio of one opioid
alone compared to the other opioid alone, P1 is the pro-
portion of one of the opioids and P2 is the proportion of
the other opioid in the total mixture.
In this study, fixed ratio proportions were selected,
first by combining the ED50 of each compound, and then
constructing a dose–response curve in which ED50 frac-
tions (1/2, 1/4, 1/8, and 1/16) of the one opioid and the
other opioid combination were administered. In the
equation above, ED50 add is the total dose and the vari-
ance of ED50 add was calculated from the fraction of the
ED50s (i.e., 0.5) in the combination as:
Var ED50 add ¼ 0:5ð Þ2 Var ED50 one opioid
þ 0:5ð Þ2Var ED50 the other opioid
From these variances, confidence limits were calcu-
lated and determined according to the ratio of the indi-
vidual drugs in the combination. The ED50 for the drug
combinations was obtained by linear regression analysis
of the dose–response curves. Supra-additivity or synergis-
tic effect is defined as the effect of a drug combination
that is higher and statistically different (ED50 significantly
lower) than the theoretically calculated equieffect of a
drug combination with the same proportions. If the ED50s
are not statistically different, the effect of the combination
is additive, and additivity means that each constituent
contributes with its own potency to the total effect.
Furthermore, the interaction index (I.I.), or the com-
bination potency to additive potency ratio, indicates the
magnitude and nature of the interaction. I.I. It was cal-
culated as :I.I. = experimental ED50/theoretical ED50.
When the value is close to 1, the interaction is ad-
ditive. Values lower than 1 are indications of the supra-
additive or synergistic interactions magnitude, and values
higher than 1 correspond to sub-additive or antagonisti-
cinteractions [5,17].
Drugs
All drugs were freshly dissolved in saline on a constant
volume of 10 ml/kg and administered as mg/kg. Mor-
phine hydrochloride, methadone hydrochloride, fentanyl
citrate, tramadol hydrochloride, naltrexone hydrochloride,
naltrindole hydrochloride and nor-BNI dihydrochloride
were purchased from Sigma Chemical Co, USA. Doses
were expressed on the basis of the salts.
Statistical analysis
Results are presented as a mean ± standard error of the
mean (SEM) or as ED50 values with 95% confidence
limits (95% CL). All calculations, including the statistical
analysis of the isobolograms related to the differencebetween experimental ED50 and theoretical ED50 values
by Student’s t test for independent means, were performed
with the program Pharm Tools Pro (version 1.27; McCary
Group Inc., PA, USA), and based on Tallarida [17]. P
values under 0.05 (P < 0.05) were considered significant.
Results
The opioid treatments in this study did not affect the
functional aspect of the mice, because no abnormality
was observed in the motor function after the opioid
treatments, even at the highest doses used in this study.
Antinociception induced by opioids
The i.p. administration of morphine (0.01, 0.03, 0.1 and
0.3 mg/kg), displayed a dose-dependent antinociceptive
activity with different efficacy in the acetic acid writhing
assay of the mice, and the ED50 resulted to be 0.124 ±
0.018 mg/kg. The administration of methadone (0.01,
0.03, 0.1 and 0.3 mg/kg), induced a dose–response curve,
and the ED50 was 0.005 ± 0.018 mg/kg. After the adminis-
tration of fentanyl (0.001, 0.003, 0.01 and 0.03 mg/kg) the
ED50resulted in 0.016 ± 0.002 mg/kg. The adminis-
tration of tramadol (1, 3, 10 and 30 mg/kg) with an
ED50 of 3.904 ± 0.495 mg/kg. The ED50 demonstrated
the following rank of efficacy: fentanyl > methadone >
morphine > tramadol. All these results are summarized
in Figure 1 and Table 1.
In the hot-plate test of mice, the same doses of opioids
induced a dose-dependent antinociception with different
efficacy. The ED50 values of fentanyl, methadone, morphine
and tramadol were 0.040, 0.24, 1.94 and 30.53 mg/kg,
respectively (see Table 2).
The rank of potency of opioids in the writhing test to
hot plate assay was from 2.5 (fentanyl) to 15.5 (morphine)
times, respectively.
Effect of naltrexone (NTX), naltrindole (NTI) and nor-BNI
in the antinociception of opioids
In the writhing test, the pretreatment with NTX, 1 mg/kg
i.p. antagonized the antinociceptive activity of the ED50
of morphine, fentanyl and methadone, but partially re-
versed the effect of tramadol. The administration of
2 mg/kg i.p. of NTI, antagonized the antinociception in-
duced by morphine and fentanyl, however, partially re-
versed the effect of methadone and tramadol. The
administration of 3 mg/kg i.p. of nor-BNI, partially an-
tagonized the antinociceptive activity of morphine and
tramadol, but there was a lack of effect in the antinoci-
ception induced by fentanyl and methadone, all these
results are summarized in Table 1. In the case of hot
plate assay, NTX antagonized the antinociceptive activ-
ity of morphine, methadone, fentanyl and tramadol. The
pretreatment with NTI antagonized the antinociceptive
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Figure 1 Dose–response curves for the antinociceptive activity in the writhing test of mice induced by fentanyl, methadone, morphine
and tramadol. Each point is the mean ± SEM of six animals. % MPE = antinociception represented as a percentage of maximum possible effect.
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the antinociception produced by all the opioids tested.
These results are summarized in Table 2. The opioid an-
tagonist doses were adapted or modified from previously
published studies that showed the pharmacological activ-
ity of each individual receptor subtype [18-23].
Interactions between opioids
The antinociceptive activity interactions of the i.p. coad-
ministration on the basis of a fixed ratio of (1:1) combin-
ation of their ED50 values alone of the different opioids
used in this work was evaluated by isobolographic
analysis.
The isobolograms demonstrated that all the mixtures of
opioids, in the writhing test of the mice, resulted in syner-
gistic interaction of different magnitudes as can be seenTable 1 ED50 values, in mg/kg ± SEM, for the antinociceptive
activity of intraperitoneal administration of fentanyl,
methadone, morphine and tramadol without and with
naltrexone (NTX) 1 mg/kg i.p., naltrindole (NTI) 2 mg/kg i.p.
and nor-BNI 3 mg/kg i.p. in the writhing test of mice
Drug ED50 ± SEM
Alone + NTX + NTI + nor-BNI
(n = 24) (n = 24) (n = 24) (n = 24)
Fentanyl 0.016 ± 0.002 3.04 ± 0.38* 2.89 ± 0.42 0.017 ± 0.003
Methadone 0.085 ± 0.005 1.45 ± 0.15* 0.065 ± 0.008 0.081 ± 0.006
Morphine 0.125 ± 0.019 2.20 ± 0.36* 1.56 ± 0.15* 0.097 ± 0.14
Tramadol 3.904 ± 0.495 4.24 ± 0.80 2.98 ± 0.35 2.86 ± 0.65
All results between opioids alone are significant (P < 0.05). *P < 0.05 comparing
with ED50 alone. n = number of animals used in each drug determination.in Figure 2 (panel A-F). Table 3 shows the theoretical
additive and the experimental ED50 values for the com-
binations with their 95% CL and their interaction index
values.
Furthermore, the interaction index values of the i.p. com-
binations on the writhing test, demonstrated the following
rank of potencies: morphine with methadone >methadone
with fentanyl >morphine with tramadol >morphine with
fentanyl >methadone with tramadol > fentanyl with tramadol
as it is shown in Table 3.
In the hot plate assay, the isobolographic analysis of
the opioids coadministration on the basis of a fixed ratio
of (1:1) combination of their ED50 values alone, resulted
in a synergistic interaction between morphine with metha-
done, methadone with fentanyl, morphine with fentanyl
and morphine with tramadol. The mixtures methadoneTable 2 ED50 values, in mg/kg ± SEM, for the
antinociceptive activity of intraperitoneal administration
of fentanyl, methadone, morphine and tramadol without
and with naltrexone (NTX) 1 mg/kg i.p., naltrindole (NTI)
2 mg/kg i.p. and nor-BNI 3 mg/kg i.p. in the hot plate test
of mice
Drug ED50 ± SEM
Alone + NTX + NTI + nor-BNI
(n = 24) (n = 24) (n = 24) (n = 24)
Fentanyl 0.040 ± 0.002 2.41 ± 0.25* 2.51 ± 0.25* 0.037 ± 0.003
Methadone 0.24 ± 0.015 0.58 ± 0.08* 0.011 ± 0.008* 0.022 ± 0.006
Morphine 1.94 ± 0.084 3.82 ± 0.36* 3.56 ± 0.15* 2.31 ± 0.44
Tramadol 30.53 ± 0.98 34.74 ± 1.25* 32.14 ± 0.53 29.75 ± 2.58
All results between opioids alone are significant (P < 0.05). *P < 0.05 when






































































































Figure 2 Isobolograms for the administration of the combination of methadone with morphine (2 A), methadone with fentanyl (2 B),
tramadol and morphine (2 C), fentanyl and morphine (2 D),tramadol with methadone (2 E) and tramadol with fentanyl (2 F), in the
writhing test of mice. Theoretical ED50 value with 95% CL (●). Experimental ED50 value with 95% CL (○).
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additive, as can be seen in Figure 3 (panel A-F). In ad-
dition, Table 4 shows the theoretical additive and the ex-
perimental ED50 values for the different combinations
with their 95% CL and their interaction index values. InTable 3 Theoretical and experimental ED50 values with 95% C
of the intraperitoneal coadministration of morphine with










*P < 0.05 compared with ED50 theoretical.this assay, the rank of potency of the interaction index
was: morphine with methadone >methadone with fen-
tanyl > morphine with fentanyl > morphine with trama-
dol >methadone with tramadol > fentanyl with tramadol
as it is shown in Table 4.L, and interaction index for the antinociceptive activity
methadone, morphine with fentanyl, and morphine
tramadol, and fentanyl with tramadol in the writhing








Figure 3 Isobolograms for the administration of the combination of methadone with morphine (3 A), methadone with fentanyl (3 B),
fentanyl and morphine (3 C), tramadol and morphine (3 D),tramadol with methadone (3 E) and tramadol with fentanyl (3 F), in the hot
plate test of mice. Theoretical ED50 value with 95% CL (●). Experimental ED50 value with 95% CL (○).
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http://www.jbiomedsci.com/content/21/1/62The relation between the interaction index, in the opi-
oid mixtures changes from 1.41 in morphine with fen-
tanyl to 2.35 in morphine with methadone, respectively,
to compare both assays. In addition, the ratio of experi-
mental ED50 of the opioid combinations, in the writhing
to hot plate tests, varied from 4 in methadone with fen-
tanyl to 25 in morphine with methadone, respectively.Table 4 Theoretical and experimental ED50 values with 95% C
of the intraperitoneal coadministration of morphine with m










*P < 0.05 compared with ED50 theoretical.Effect of naltrexone (NTX), naltrindole (NTI) and nor-BNI
in the interactions of opioids
Using the writhing test, NTX antagonized the antinoci-
ceptive activity of the coadministration of methadone
with fentanyl, morphine with methadone, morphine with
fentanyl, morphine with tramadol, methadone with tra-
madol, and fentanyl with tramadol. The pretreatmentL, and interaction index for the antinociceptive activity
ethadone, morphine with fentanyl, and morphine with
adol, and fentanyl with tramadol in the hot plate test








Table 6 Experimental ED50 values, without and with
naltrexone (NTX) 1 mg/kg i.p., naltrindole (NTI) 2 mg/kg
i.p. and nor-BNI 3 mg/kg i.p. for the antinociceptive activity
of the intraperitoneal coadministration of morphine with
methadone, morphine with fentanyl, and morphine with
tramadol, fentanyl with methadone, methadone with
tramadol, and fentanyl with tramadol in the hot plate test
of mice
Drugs Experimental ED50
Alone +NTX +NTI + nor-BNI
(n = 24) (n = 24) (n = 24) (n = 24)
Methadone/fentanyl 0.08 0.12* 0.15* 0.07
Morphine/Methadone 0.58 0.97* 0.89* 0.49
Morphine/fentanyl 0.60 0.97* 1.02* 0.58
Morphine/tramadol 11.20 14.41* 13.45* 10.58
Methadone/tramadol 15.51 15.30 14.89 14.52
Fentanyl/tramadol 16.00 15.65 15.02 15.61
*P < 0.05 compared with ED50 experimental alone.
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all mixture of opioids. In addition, mice pretreated with
nor-BNI, the κ-opioid antagonist lack of effect in the
antinociception produced by all the different combin-
ation of opioids. All these results are summarized in
Table 5.
In the hot plate assay, NTX was able to antagonize the
antinociception induced by the combinations of mor-
phine with methadone, methadone with fentanyl, mor-
phine with fentanyl and morphine with tramadol. NTX
did not induced changes in the analgesic activity of
methadone with tramadol and fentanyl with tramadol.
The pretreatment of the mice with NTI, reply the antag-
onistic activity of NTX, however nor-BNI lack of block-
ing action in all the combinations of opioids. See all
these results in Table 6.
Discussion
Opioids are the foremost drugs in the pharmacological
treatment of pain.
However, they have not been compared extensively in
different animal pain models. The writhing test is a
model of visceral acute pain, it is very useful when draw-
ing up directions for the therapeutic administration of
drugs in humans [14]. This model was selected because
it closely resembles clinical relevant acute post operatory
pain in humans [24].
The results obtained in this work, demonstrate that
the different opioids used in this work – fentanyl the
most potent and tramadol the least potent – produced
antinociceptive activity in the acetic acid writhing test
and in the hot plate assay. The analysis of the ED50
values of four opioids reveal different efficacies depend-
ing on the selective opioid receptor ligands. Thus theTable 5 Experimental ED50 values, without and with
naltrexone (NTX) 1 mg/kg i.p., naltrindole (NTI) 2 mg/kg
i.p. and nor-BNI 3 mg/kg i.p. for the antinociceptive activity
of the intraperitoneal coadministration of morphine with
methadone, morphine with fentanyl, and morphine with
tramadol, fentanyl with methadone, methadone with
tramadol, and fentanyl with tramadol in the writhing test
of mice
Drugs Experimental ED50
Alone +NTX +NTI + nor-BNI
(n = 24) (n = 24) (n = 24) (n = 24)
Methadone/fentanyl 0.019 0.048* 0.21* 0.018
Morphine/Methadone 0.023 0.095* 0.089* 0.019
Morphine/fentanyl 0.034 0.061* 0.058* 0.027
Morphine/tramadol 0.811 1.05* 1.10* 0.752
Fentanyl/tramadol 1.023 1.27* 1.31* 1.010
Methadone/tramadol 1.032 1.25* 1.32* 1.024
*P < 0.05 compared with ED50 experimental alone.binding potencies in nmol for MOR are 0.39 for fen-
tanyl, 0.72 for methadone and 14 for morphine [2,25]. In
the case of the racemic tramadol, the (+) enantiomer
had a binding potency value of only 1.33 and the (−) en-
antiomer had even lower affinity of 24.8 for MOR [26].
Also, the degree of lipophilicity could help to correlate
the difference between the ED50 of the opioids. Conse-
quently, high-efficacy ligands, such as fentanyl and metha-
done possesses a higher ED50 compared to lower efficacy
ligands such as morphine with a lower ED50 [2,27].
The findings of this study are in agreement with previ-
ous works. So, morphine induced analgesia in acetic acid
writhing test, with a dose range from 0.12 – 2.67 mg/kg
[28,29] and tramadol produced antinociceptive activity
in the same test with doses between 3.9 to 14.73 mg/kg
[6]. Besides, the analgesic effect produced by fentanyl
was reported at 0.016 – 0.03 mg/kg, by using the same
assay utilized in this work [29,30]. In addition, metha-
done at 0.085 to 0.467 mg/kg, produced antinociception
in the acetic acid writhing test [31]. Also, in the hot plate
the findings are concordant with previous works. So,
antinociceptive effects of morphine, fentanyl, tramadol
and their combination it has been described [29,32] and
also the methadone induced antinociception [33].
After i.p. administration of morphine with methadone
or morphine with fentanyl or morphine with tramadol;
methadone with fentanyl or methadone with tramadol,
and fentanyl plus tramadol in the writhing test a syner-
gic interaction was obtained. In the hot plate assay, the
same combination of opioids resulted in a synergic inter-
action, except of the additivity interaction induced by
tramadol with methadone or fentanyl. These results cor-
roborate that this work supports the general premises of
interactions between drugs with the same effect but
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one possibility in these interactions could be due to dif-
ferent types of the MOR receptor splice variant, where
each one of them may use a different downstream signal-
ling pathway, or it may be expressed in a different ana-
tomical region to exhibit a distinctive pharmacological
profile [34]. Moreover, hetero dimerization of the MOR
and other receptor may express another mechanisms in a
characteristic opioid efficacy, since the intracellular signal-
ling can be altered by receptor dimerization [35].
On the other hand, it is likely that the interactions ob-
served when combining morphine, methadone, fentanyl
and tramadol, could be related to multiple events that
underlying in the mechanisms of the different efficacy
among these opioids and dependent of pain stimulus.
The opioid interactions described, could occur at one
or more levels of cell functions including receptors, ion
channels, lipids and protein of the membrane, second
messengers, protein kinases, gene induction, or others.
These interaction events are dependent on the local con-
centration of opioids and on the nature of the nocicep-
tive stimulus and its transduction mechanisms [36].
The administration of acetic acid solution induces
nociception by increasing the levels of prostaglandins at
the peritoneum [37]. The inhibition induced by opioids
in the number of writhes produced by the administra-
tion of an acetic acid solution in mice in this work, sug-
gests the involvement of peripheral pain receptors. This
also help explain the interactions obtained in this study,
the fact that methadone is a mixed enantiomer with not
only MOR agonist but also N-methyl-D-aspartate recep-
tor antagonist and GABA antagonists, as morphine. This
condition could increase the analgesic activity of other
MOR agonists like morphine, fentanyl and tramadol [38].
Additionally, the nonopioid component of tramadol,
the inhibition reuptake of norepinephrine and serotonin,
could play an important role in the synergism obtained
in this work.
The use of opioid antagonists help to understand the
interactions induced by different combinations of opiods.
Thus, morphine effects are due to the activation of MOR
subtypes with partially contribution of DOR and KOR
subtypes. However, the combinations of fentanyl and
methadone are partially due to the activation of MOR
and DOR subtypes and lack of participation of KOR
subtypes. The analgesic effects of the combination of
tramadol with the other opiods, are partially due to
the activation of MOR, DOR and KOR opioid sub-
types, beside their activity on noradrenaline and sero-
tonin reuptake.
Conclusion
In conclusion the results from this work could be explained
by the complex pharmacology of opioids, accompanied bya variation in the spectrum of opioids which could be
dependent of the chemical structure, physicochemical
properties, dose, receptor binding, distribution and me-
tabolism. These results provide evidence that the effec-
tiveness and magnitude of the interactions between
opioids are dependent on the intensity of the pain sti-
mulus in acute pain states. The use of lower doses of
opioids in this work may have some utility in the clinical
treatment of pain and reduce some of the adverse ef-
fects often associated with opioid administration.
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